Indian Pacing Electrophysiol. J.
Indian Pacing Electrophysiol. J. 2008;
Influence of Intrinsic Myocardial Conduction on Paced QRS Morphology During Cardiac Resynchronization Therapy Follow up
Download PDF 836 KBRajendra Deshmukh, MD, K Latchumanadhas, MD, DM, Ajit S Mullasari, MD, DM, Ulhas M Pandurangi, MD, DM.
Institute of Cardiovascular Diseases, Madras Medical Mission, 4A, Dr. J.J.Nagar, Mogappair, Chennai - 600 037. India.
Address for correspondence: Dr. Ulhas M.Pandurangi, Department of Cardiology, Institute of Cardiovascular Diseases, Madras Medical Mission, 4A, Dr. J.J.Nagar, Mogappair, Chennai - 600 037. E-mail: icvddoctors/at/mmm.org.in
We report two cases of patients of cardiac resynchronization therapy (CRT) whose ECGs, during follow up, showed different paced QRS morphology as compared to those of immediate post-device implantation. Parameters of leads, including sensitivity and capture thresholds, were unchanged. There was no lead dislodgement confirmed on fluoroscopy. The ECGs obtained in device off mode showed different intrinsic QRS morphology as compared to those of pre-implant morphology. These changes were attributable to electrolyte imbalance in one patient and progressive intraventricular conduction defect in the other. These cases demonstrate that intrinsic myocardial conduction pattern influences paced QRS morphology. Irreversible change in paced QRS morphology may indicate poor prognosis.
Key Words: Cardiac resynchronization therapy; wide QRS; hyperkalemia; myocardial disease
Change in the paced QRS morphology in patients with CRT devices can be due to loss of capture, dislodgement of ventricular pacing leads, change in the pacing timing of ventricular leads (V-V delay) as well as electrolyte and acid base imbalance without significant change in threshold1,2. Influence of change in intrinsic myocardial conduction pattern on paced QRS morphology has not been studied well so far.
Here we present two case reports in which change in paced QRS morphology was attributable exclusively to change in the intrinsic myocardial conduction pattern without change in lead parameters or position. In one case the change in intramyocardial conduction pattern was due to electrolyte imbalance and in another it was due to progression of myocardial disease.
A 66 years old diabetic male with ischaemic cardiomyopathy had undergone CRT for symptomatic congestive heart failure despite optimal medical management. His baseline ECG (Figure 1a) showed sinus rhythm, complete RBBB with QRS duration of 130ms. The post-implant ECG (Figure 1b) showed sinus rhythm and paced QRS duration of 100 ms with North West QRS axis. Left ventricle was set to be paced 40 ms earlier than RV, to achieve optimal synchronization based on echocardiographic parameters.
Figure 1a: Baseline ECG with wide QRS (RBBB)
Figure 1b: Post implant ECG
The patient was doing well for 18 months following CRT, then presented to us with altered sensorium of 6 hours duration. There was no history of dyspnea, angina or palpitation. His ECG (Figure 2a) showed atrial paced and biventricular paced rhythm. However the paced QRS morphology was significantly different as compared to previous post-implant ECGs. The QRS duration (210 ms) was wider by 110 ms. Interrogation of the device revealed no significant changes in lead parameters and ventricular capture thresholds. Fluoroscopy revealed no lead dislodgement. ECG (Figure 2b) obtained when the device was temporarily switched off showed wider QRS complexes (150 ms) as compared to pre-implant ECG with prolonged PR interval (260 ms) and left axis deviation.
Figure 2a: ECG showing widening of paced QRS due to hyperkalemia
Figure 2b: ECG with device in switched off mode
His biochemical parameters revealed hyperglycemia (random blood sugar 400mg/dl) and hyperkalemia (serum potassium 6.5 mEq/L). Ketones were present in blood and urine. Renal parameters were mildly deranged (urea 50 mg/dl, creatinine 1.6 mg/dl). He was treated for metabolic encephalopathy with diabetic ketoacidosis. Over a period of 36 hours when biochemical and electrolyte parameters returned to normal, patient became asymptomatic, with clear sensorium. The morphology of paced QRS complex on surface ECG as well as that of intrinsic QRS became identical to that of immediate post-implant ECG.
A 38 years lady with idiopathic dilated cardiomyopathy underwent CRT for refractory heart failure despite optimal medical management. Pre-implant ECG showed (Figure 3a) - sinus rhythm, prolonged PR interval (220ms), complete LBBB, QRS duration of 120ms and left axis. Post-implant ECG (Figure 3b), after optimizing her A-V & V-V delays showed sinus rhythm, QRS duration of 100 ms and left axis. Left ventricle was set to be paced 40 ms earlier than RV. She was doing well for 15 months after which she started becoming breathless. Breathlessness gradually worsened over a period of one month and she presented to us with complaints of orthopnea and reduced urine output. On admission patient was in pulmonary oedema and her ECG (Figure 4a) showed atrial sensed, biventricular paced rhythm. However the paced QRS morphology was significantly different and wider as compared to previous post-implant ECGs. The QRS complexes were of RBBB morphology with superior axis. The QRS duration (180 ms) was wider by 60 milliseconds. Lead(s) dislodgement or capture failure was suspected.
Figure 3a: Baseline ECG with wide QRS (lBBB)
Figure 3b: Post implant ECG
Figure 4a: ECG showing widening of paced QRS due to progressive disease
Figure 4b: ECG with device in switched off mode
However device interrogation and fluoroscopy ruled out lead and device related issues. The ECG (Figure 4b) obtained when the device was temporarily switched off showed wider QRS complexes (168 ms) with prolonged PR interval (200 ms) and atrial enlargement as compared to pre-implant ECG. Echocardiography revealed severe biventricular dysfunction with increase in size of chambers as compared to one-year follow up. She had mildly elevated renal parameters (urea 47 mg/dl, creatinine 1.4 mg/dl) with normal electrolytes. She was stabilized with diuretics and additional inotropic support. After 10 days, at the time of discharge, the QRS morphology (on and off pacing) continued to be wider. Patient ultimately succumbed to progressive pump failure 2 months later.
In addition to mechanical synchrony, electrical synchrony is also achieved in majority of patients with CRT3,4. Electrical synchrony manifests on ECG as reduction in the width of QRS5,6. The changes in the paced QRS morphology can be due to loss of capture, lead dislodgement, electrolyte imbalance and drugs like amiodarone1,2. The changes in the morphology of QRS can also be due to progression of intrinsic disease involving myocardium and conduction system7. Hyperkalemia in CHF is usually a consequence of associated renal dysfunction or drug therapy (angiotensin converting enzyme inhibitors, angiotensin receptor blockers, potassium sparing diuretics etc.) or both. Hyperkalemia causes changes in the paced QRS morphology by the following mechanisms. An increase in the concentration of extra cellular potassium lowers the resting membrane potential, leading to a reduction of the upstroke velocity, amplitude, and duration of the action potential. This effect has been recorded in atrial, ventricular, and Purkinje fibers and is manifest on the ECG by changes in the amplitude and duration of the P wave and the QRS complex8. A mild to moderate hyperkalemia causes increase in myocardial excitability but further increase leads to impaired myocardial responsiveness to pacing stimulus9. It may produce various degrees of exit blocks10,11. In our first patient renal impairment and angiotensin converting enzyme inhibitor were considered to be the culprits responsible for hyperkalemia. Measures initiated to normalize potassium levels, promptly restored the paced QRS morphology as well as intrinsic QRS morphology.
Progression of myocardial disease per se has been shown to progressively widen the QRS complex in idiopathic dilated cardiomyopathy12,13. Increasing size of cardiac chambers, and concomitant involvement of conduction system by the disease process has been implicated for the change in QRS morphology14,15. In our second case the change in intrinsic QRS morphology was due to progression of underlying disease. The fulminant course leading to death in this patient suggests that change in the paced QRS morphology in the absence of known causes is a sign of poor prognosis.
To the best of our knowledge there has been no published case reports describing hyperkalemia and progressive myocardial disease as reasons for changes in the paced QRS morphology in CRT patients.
Irreversible change in the paced QRS morphology during CRT follow up can be due to gradual progression of underlying cardiomyopathy. This phenomenon is indicative of poor prognosis. Reversible changes in the paced QRS morphology carry a benign prognosis. These changes may be due to underlying electrolyte abnormality like hyperkalemia.
1. Aranda JM, Woo GW, Schofield RS, Handberg EM, Hill JA, et al. Management of heart failure after cardiac resynchronization therapy. J Am Coll Cardiol 2005; 46:2193-2198.
2. Barold SS, Leonelli F, Herweg B. Hyperkalemia during cardiac pacing. Pacing Clin Electrophysiol 2007; 30:1-3.
Molhoek SG, Erven VL, Boersma E, Steednijk P, Van Der Wall EE, et al. QRS duration and shortening to predict clinical response to cardiac resynchronization therapy in patients with end-stage heart failure. Pacing Clin Electrophysiol 2004; 27:308-313.
4. Tournoux F, Leclercq C, DePlace C, Crocq C, Solnon A, et al. Concordance between mechanical and electrical dyssynchrony in heart failure patients. J Cardiovasc Electrophysiol 2007; 18:1022-1027.
Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 6:2183–2192.
6. Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, et al. Clinical and electrocardiographic predictors of a positive response to cardiac resynchroniozation therapy in advanced heart failure. European Heart Journal 2005; 26:1094-1100.
7. Xiao HB, Roy C, Fujimoto S, Gibson DG. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. Int J Cardiol 1996; 53:163-170.
8. Lichstein E, Gupta PK, Grunwald AA. Hyperkalemic fascicular block. Chest 1976; 70:290-291.
10. Tomcsanyi J. Extremely wide QRS complex with VVI pacing. Pacing Clin Electrophysiol 2002; 25:1128-1129.
11. Bashour T, Hsu I, Gorfinkel HJ, Wickramesekaran R, Rios JC. Atrioventricular and intraventricular conduction in hyperkalemia. Am J Cardiol 1975; 35:199-203.
12. Wilensky RL, Yudelman P, Cohen AI, Fletcher RD, Atkinson J, et al. Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. Am J Cardiol 1988; 62:276-283.
13. Xiao HB, Roy C, Gibson DG. Nature of ventricular activation in patients with dilated cardiomyopathy: evidence for bilateral bundle branch block. Br Heart J.1994; 72:167-174.
14. Leclercq C, Kass DA. Retiming the failing heart: principles and current clinical status of cardiac resynchronization. J Am coll Cardiol 2002; 39:194-201.
15. Dias RA, Obasohan A, Oakley CM. Prediction of outcome in dilated cardiomyopathy. Br Heart J 1987; 58:393-399.